These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 28906003)
41. Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial. Koch T; Dahlke C; Fathi A; Kupke A; Krähling V; Okba NMA; Halwe S; Rohde C; Eickmann M; Volz A; Hesterkamp T; Jambrecina A; Borregaard S; Ly ML; Zinser ME; Bartels E; Poetsch JSH; Neumann R; Fux R; Schmiedel S; Lohse AW; Haagmans BL; Sutter G; Becker S; Addo MM Lancet Infect Dis; 2020 Jul; 20(7):827-838. PubMed ID: 32325037 [TBL] [Abstract][Full Text] [Related]
42. Antigen Capture Enzyme-Linked Immunosorbent Assay for Detecting Middle East Respiratory Syndrome Coronavirus in Humans. Fung J; Lau SKP; Woo PCY Methods Mol Biol; 2020; 2099():89-97. PubMed ID: 31883089 [TBL] [Abstract][Full Text] [Related]
43. Antibodies and vaccines against Middle East respiratory syndrome coronavirus. Xu J; Jia W; Wang P; Zhang S; Shi X; Wang X; Zhang L Emerg Microbes Infect; 2019; 8(1):841-856. PubMed ID: 31169078 [TBL] [Abstract][Full Text] [Related]
44. A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV. Zhao G; He L; Sun S; Qiu H; Tai W; Chen J; Li J; Chen Y; Guo Y; Wang Y; Shang J; Ji K; Fan R; Du E; Jiang S; Li F; Du L; Zhou Y J Virol; 2018 Sep; 92(18):. PubMed ID: 29950421 [TBL] [Abstract][Full Text] [Related]
45. Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus. Deng Y; Lan J; Bao L; Huang B; Ye F; Chen Y; Yao Y; Wang W; Qin C; Tan W Emerg Microbes Infect; 2018 Apr; 7(1):60. PubMed ID: 29618723 [TBL] [Abstract][Full Text] [Related]
46. Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle East respiratory syndrome coronavirus. Kim MH; Kim HJ; Chang J PLoS One; 2019; 14(7):e0220196. PubMed ID: 31329652 [TBL] [Abstract][Full Text] [Related]
47. Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein. Widjaja I; Wang C; van Haperen R; Gutiérrez-Álvarez J; van Dieren B; Okba NMA; Raj VS; Li W; Fernandez-Delgado R; Grosveld F; van Kuppeveld FJM; Haagmans BL; Enjuanes L; Drabek D; Bosch BJ Emerg Microbes Infect; 2019; 8(1):516-530. PubMed ID: 30938227 [TBL] [Abstract][Full Text] [Related]
48. A sensitive and specific antigen detection assay for Middle East respiratory syndrome coronavirus. Chen Y; Chan KH; Kang Y; Chen H; Luk HK; Poon RW; Chan JF; Yuen KY; Xia N; Lau SK; Woo PC Emerg Microbes Infect; 2015 Apr; 4(4):e26. PubMed ID: 26421268 [TBL] [Abstract][Full Text] [Related]
49. MERS-CoV spike protein: Targets for vaccines and therapeutics. Wang Q; Wong G; Lu G; Yan J; Gao GF Antiviral Res; 2016 Sep; 133():165-77. PubMed ID: 27468951 [TBL] [Abstract][Full Text] [Related]
50. Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infection. Jia W; Channappanavar R; Zhang C; Li M; Zhou H; Zhang S; Zhou P; Xu J; Shan S; Shi X; Wang X; Zhao J; Zhou D; Perlman S; Zhang L Emerg Microbes Infect; 2019; 8(1):760-772. PubMed ID: 31130102 [TBL] [Abstract][Full Text] [Related]
51. A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations. Grzelak L; Temmam S; Planchais C; Demeret C; Tondeur L; Huon C; Guivel-Benhassine F; Staropoli I; Chazal M; Dufloo J; Planas D; Buchrieser J; Rajah MM; Robinot R; Porrot F; Albert M; Chen KY; Crescenzo-Chaigne B; Donati F; Anna F; Souque P; Gransagne M; Bellalou J; Nowakowski M; Backovic M; Bouadma L; Le Fevre L; Le Hingrat Q; Descamps D; Pourbaix A; Laouénan C; Ghosn J; Yazdanpanah Y; Besombes C; Jolly N; Pellerin-Fernandes S; Cheny O; Ungeheuer MN; Mellon G; Morel P; Rolland S; Rey FA; Behillil S; Enouf V; Lemaitre A; Créach MA; Petres S; Escriou N; Charneau P; Fontanet A; Hoen B; Bruel T; Eloit M; Mouquet H; Schwartz O; van der Werf S Sci Transl Med; 2020 Sep; 12(559):. PubMed ID: 32817357 [TBL] [Abstract][Full Text] [Related]
52. Live-attenuated bivalent measles virus-derived vaccines targeting Middle East respiratory syndrome coronavirus induce robust and multifunctional T cell responses against both viruses in an appropriate mouse model. Bodmer BS; Fiedler AH; Hanauer JRH; Prüfer S; Mühlebach MD Virology; 2018 Aug; 521():99-107. PubMed ID: 29902727 [TBL] [Abstract][Full Text] [Related]
53. One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus. Wirblich C; Coleman CM; Kurup D; Abraham TS; Bernbaum JG; Jahrling PB; Hensley LE; Johnson RF; Frieman MB; Schnell MJ J Virol; 2017 Jan; 91(2):. PubMed ID: 27807241 [TBL] [Abstract][Full Text] [Related]
54. A high-throughput inhibition assay to study MERS-CoV antibody interactions using image cytometry. Rosen O; Chan LL; Abiona OM; Gough P; Wang L; Shi W; Zhang Y; Wang N; Kong WP; McLellan JS; Graham BS; Corbett KS J Virol Methods; 2019 Mar; 265():77-83. PubMed ID: 30468747 [TBL] [Abstract][Full Text] [Related]
55. MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015. Choe PG; Perera RAPM; Park WB; Song KH; Bang JH; Kim ES; Kim HB; Ko LWR; Park SW; Kim NJ; Lau EHY; Poon LLM; Peiris M; Oh MD Emerg Infect Dis; 2017 Jul; 23(7):1079-1084. PubMed ID: 28585916 [TBL] [Abstract][Full Text] [Related]
56. Serologic Follow-up of Middle East Respiratory Syndrome Coronavirus Cases and Contacts-Abu Dhabi, United Arab Emirates. Al Hosani FI; Kim L; Khudhair A; Pham H; Al Mulla M; Al Bandar Z; Pradeep K; Elkheir KA; Weber S; Khoury M; Donnelly G; Younis N; El Saleh F; Abdalla M; Imambaccus H; Haynes LM; Thornburg NJ; Harcourt JL; Miao C; Tamin A; Hall AJ; Russell ES; Harris AM; Kiebler C; Mir RA; Pringle K; Alami NN; Abedi GR; Gerber SI Clin Infect Dis; 2019 Jan; 68(3):409-418. PubMed ID: 29905769 [TBL] [Abstract][Full Text] [Related]
57. Pan-beta-coronavirus subunit vaccine prevents SARS-CoV-2 Omicron, SARS-CoV, and MERS-CoV challenge. Wang G; Verma AK; Guan X; Bu F; Odle AE; Li F; Liu B; Perlman S; Du L J Virol; 2024 Sep; 98(9):e0037624. PubMed ID: 39189731 [TBL] [Abstract][Full Text] [Related]
58. Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study. Müller MA; Meyer B; Corman VM; Al-Masri M; Turkestani A; Ritz D; Sieberg A; Aldabbagh S; Bosch BJ; Lattwein E; Alhakeem RF; Assiri AM; Albarrak AM; Al-Shangiti AM; Al-Tawfiq JA; Wikramaratna P; Alrabeeah AA; Drosten C; Memish ZA Lancet Infect Dis; 2015 May; 15(5):559-64. PubMed ID: 25863564 [TBL] [Abstract][Full Text] [Related]
59. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding. Byrnes JR; Zhou XX; Lui I; Elledge SK; Glasgow JE; Lim SA; Loudermilk RP; Chiu CY; Wang TT; Wilson MR; Leung KK; Wells JA mSphere; 2020 Sep; 5(5):. PubMed ID: 32938700 [TBL] [Abstract][Full Text] [Related]
60. Particulate multivalent presentation of the receptor binding domain induces protective immune responses against MERS-CoV. Okba NMA; Widjaja I; van Dieren B; Aebischer A; van Amerongen G; de Waal L; Stittelaar KJ; Schipper D; Martina B; van den Brand JMA; Beer M; Bosch BJ; Haagmans BL Emerg Microbes Infect; 2020 Dec; 9(1):1080-1091. PubMed ID: 32471334 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]